AU Patent

AU2017272232C1 — Treatment of brain cancer

Assigned to Array Biopharma Inc · Expires 2019-08-15 · 7y expired

What this patent protects

[00159] Compounds for the treatment of brain cancer are provided herein. Pharmaceutical compositions comprised of those compounds for the treatment of brain cancer are also provided herein.

USPTO Abstract

[00159] Compounds for the treatment of brain cancer are provided herein. Pharmaceutical compositions comprised of those compounds for the treatment of brain cancer are also provided herein.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017272232C1
Jurisdiction
AU
Classification
—
Expires
2019-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.